High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.
Publication
, Journal Article
Shpall, EJ; Clarke-Pearson, D; Soper, JT; Berchuck, A; Jones, RB; Bast, RC; Ross, M; Lidor, Y; Vanacek, K; Tyler, T
Published in: Gynecol Oncol
September 1990
Duke Scholars
Published In
Gynecol Oncol
DOI
ISSN
0090-8258
Publication Date
September 1990
Volume
38
Issue
3
Start / End Page
386 / 391
Location
United States
Related Subject Headings
- Transplantation, Autologous
- Thiotepa
- Ovarian Neoplasms
- Oncology & Carcinogenesis
- Middle Aged
- Humans
- Female
- Cyclophosphamide
- Combined Modality Therapy
- Cisplatin
Citation
APA
Chicago
ICMJE
MLA
NLM
Shpall, E. J., Clarke-Pearson, D., Soper, J. T., Berchuck, A., Jones, R. B., Bast, R. C., … Tyler, T. (1990). High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. Gynecol Oncol, 38(3), 386–391. https://doi.org/10.1016/0090-8258(90)90079-z
Shpall, E. J., D. Clarke-Pearson, J. T. Soper, A. Berchuck, R. B. Jones, R. C. Bast, M. Ross, Y. Lidor, K. Vanacek, and T. Tyler. “High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.” Gynecol Oncol 38, no. 3 (September 1990): 386–91. https://doi.org/10.1016/0090-8258(90)90079-z.
Shpall EJ, Clarke-Pearson D, Soper JT, Berchuck A, Jones RB, Bast RC, et al. High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. Gynecol Oncol. 1990 Sep;38(3):386–91.
Shpall, E. J., et al. “High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.” Gynecol Oncol, vol. 38, no. 3, Sept. 1990, pp. 386–91. Pubmed, doi:10.1016/0090-8258(90)90079-z.
Shpall EJ, Clarke-Pearson D, Soper JT, Berchuck A, Jones RB, Bast RC, Ross M, Lidor Y, Vanacek K, Tyler T. High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. Gynecol Oncol. 1990 Sep;38(3):386–391.
Published In
Gynecol Oncol
DOI
ISSN
0090-8258
Publication Date
September 1990
Volume
38
Issue
3
Start / End Page
386 / 391
Location
United States
Related Subject Headings
- Transplantation, Autologous
- Thiotepa
- Ovarian Neoplasms
- Oncology & Carcinogenesis
- Middle Aged
- Humans
- Female
- Cyclophosphamide
- Combined Modality Therapy
- Cisplatin